BELLEVUE CAPITAL PARTNERS, LLC ANNOUNCES FINAL RESULTS OF TENDER OFFER FOR SHARES OF AMERICAN STRATEGIC INVESTMENT CORP.
- 78
PR Newswire
NEW YORK, July 16, 2024
NEW YORK, July 16, 2024 /PRNewswire/ -- Bellevue Capital Partners, LLC ("Bellevue") announced today the final results of its tender offer to purchase for cash up to 125,000 shares of American Strategic Investment Co. (NYSE: NYC) ("ASIC") common stock at a price of $11.00 per share (the "Tender Offer"), which expired at 5:00 p.m., New York City time, on July 15, 2024.
Based on the final count by Computershare Trust Company, N.A., the depositary for the tender offer, 179,219 shares of ASIC's common stock were properly tendered and not properly withdrawn.
The tender offer was oversubscribed. Pursuant to the terms of the offer, 125,000 shares of ASIC's common stock were accepted for purchase on a pro rata basis, for an aggregate cost of approximately $1,375,000, in cash, less any fees, expenses or applicable withholding taxes relating to the tender offer. The repurchased shares represent approximately 4.85% of ASIC's shares outstanding as of May 2, 2024.
Computershare Trust Company, N.A., the depositary for the tender offer, will promptly issue payment for the shares of ASIC common stock validly tendered and accepted for purchase in the tender offer, and will return all other shares tendered and not purchased in the tender offer.
About Bellevue Capital Partners, LLC
Bellevue is a leading, diversified investment, asset management and operating platform and the sole member of AR Global Investments, LLC, the parent company to the advisor and property manager of ASIC.
View original content to download multimedia:https://www.prnewswire.com/news-releases/bellevue-capital-partners-llc-announces-final-results-of-tender-offer-for-shares-of-american-strategic-investment-corp-302198701.html
SOURCE Bellevue Capital Partners, LLC
- EQS-News: www.fondsboutiquen.de: Jahrestagung Family Offices & Finanzplatz Frankfurt trifft Finanzplatz Liechtenstein - Family Office & Fondsboutiquen (Veranstaltungen: 19.9. - 20.9. & 29.10.2024)
- EQS-News: CureVac CVGBM Krebsimpfstoff induziert vielversprechende Immunantworten in Phase-1-Studie beim Glioblastom; Präsentation auf dem ESMO-Kongress 2024
- SDAIA und Microsoft gründen Exzellenzzentrum zur Förderung von KI-Transformation und Innovation
- EQS-News: Dr. Greger & Collegen: 'Opfer von Trading- und Kryptobetrug? Perfide Strategien und falsche Versprechen'
- EQS-News: Ordentliche Hauptversammlung der Northern Data AG
- AI-Media und Speechmatics geben strategische Partnerschaft zur Entwicklung von Untertitelungs- und Sprachtechnologien bekannt